Dec 24, 2011 by Xconomy .comBeyond the Tablet Wars: Apple, Amazon, and the CloudWhat makes them both great will keep them great for years to come.
Dec 20, 2011 by Xconomy .comAT&T Drops T-Mobile Bid, Will Pay $4B Breakup FeeBut what about the spectrum deal?
Dec 20, 2011 by Xconomy .comAmgen, Watson Strike $400M Deal for Biosimilar Cancer DrugsWhat does this important collaboration mean for biosimilars?
Dec 20, 2011 by Xconomy .comWhat Now? Reactions, Questions After the AT&T-Mo FailureAre T-Mobile and Sprint the next hottest couple in wireless?
Dec 15, 2011 by Xconomy .comVertex Names Jeff Leiden as New CEO, Staring Down Tough CompetitionWhat does new leadership mean for Vertex's future?
Dec 14, 2011 by Xconomy .comZillow Shows Why Microsoft Might Love the Kindle Fire: No Google MapsNo Google Maps!
Dec 8, 2011 by Xconomy .comAffymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia DrugMany investors wrote off Affymax in June 2010, but was that premature?
Nov 22, 2011 by Xconomy .comPfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive ScarringPfizer is making a new bet on a new drug to fight excessive scarring.
Nov 19, 2011 by Xconomy .comRegeneron Wins FDA Approval for Macular-Degeneration DrugThe company can begin selling Eylea, which treats the leading cause of blindness in the elderly.
Nov 10, 2011 by Xconomy .comAmazon Pushing National Sales-Tax BillLooks like Amazon.com's pugnacious bet on national sales tax reform is paying off.
Nov 4, 2011 by Xconomy .comCelgene To Pump $45M into Quanticel to Discover Cancer Drugs, Gets Option To AcquireCelgene strikes an unusual agreement.
Oct 11, 2011 by Xconomy .comAgios and Celgene: Anatomy of an Ultra-Valuable Biotech MarriageAn unprecedented cancer drug development deal.
Oct 8, 2011 by Xconomy .comSprint Makes It Pretty Clear: Clearwire's on Its OwnShares plummet as Sprint unveils plans that don't include the WiMax provider.
Oct 6, 2011 by Xconomy .comHow Steve Jobs Rewired Our Lives -- and Raised Our ExpectationsSteve Jobs' real legacy.
Oct 5, 2011 by Xconomy .comMerck Fine-Tunes Biosimilars Strategy as FDA Guidelines LoomMerck readies itself to enter this potential new market.
Sep 28, 2011 by Xconomy .comWhy Amazon’s Tablet Matters: It’s Not a Computer. It’s a Store.Is this the iPad killer after all?
Sep 24, 2011 by Xconomy .comWhat the Changes at Facebook Mean for Apple and Google -- and YouTurning the social network inside out.
Sep 21, 2011 by Xconomy .comOrexigen Revives Obesity Drug After One More Go-Round With FDAOrexigen has new life.
Sep 8, 2011 by Xconomy .comBristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and BayerWho will come out ahead?
Aug 26, 2011 by Xconomy .comSteve Jobs Calling: The Stuff of Customer Service LegendWhat kind of company will Apple be without Jobs?
